Cargando…

Effects of Growth Hormone and Pioglitazone in Viscerally Obese Adults with Impaired Glucose Tolerance: A Factorial Clinical Trial

OBJECTIVE: Recombinant human growth hormone (GH) and pioglitazone (PIO) in abdominally obese adults with impaired glucose tolerance were evaluated under the hypothesis that the combination attenuates GH-induced increases in glucose concentrations, reduces visceral adipose tissue (VAT), and improves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Attallah, Hamdee, Friedlander, Anne L, Nino-Murcia, Matilde, Hoffman, Andrew R
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1865086/ https://www.ncbi.nlm.nih.gov/pubmed/17479164 http://dx.doi.org/10.1371/journal.pctr.0020021

Ejemplares similares

How Does Pioglitazone Prevent Progression of Impaired Glucose Tolerance to Diabetes?
por: Genuth, Saul M.
Publicado: (2013)

Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance
por: Espinoza, Sara E., et al.
Publicado: (2016)

Pioglitazone Improves In Vitro Viability and Function of Endothelial Progenitor Cells from Individuals with Impaired Glucose Tolerance
por: Spigoni, Valentina, et al.
Publicado: (2012)

Central sensitivity to thyroid hormones is reduced in youths with overweight or obesity and impaired glucose tolerance
por: Di Bonito, Procolo, et al.
Publicado: (2023)

Predictors of deterioration of glucose tolerance and effects of lifestyle intervention aimed at reducing visceral fat in normal glucose tolerance subjects with abdominal obesity
por: Akita, Etsuko F, et al.
Publicado: (2010)

Visceral Fat Accumulation Is Associated With Circadian Blood Pressure in Japanese Patients With Impaired Glucose Tolerance
por: Masaki, Takayuki, et al.
Publicado: (2011)

Insulin‐secretion capacity in normal glucose tolerance, impaired glucose tolerance, and diabetes in obese and non‐obese Japanese patients
por: Iwahashi, Hiromi, et al.
Publicado: (2012)

Improved Insulin Sensitivity during Pioglitazone Treatment Is Associated with Changes in IGF-I and Cortisol Secretion in Type 2 Diabetes and Impaired Glucose Tolerance
por: Arnetz, Lisa, et al.
Publicado: (2013)

Stratified glucose-lowering response to vildagliptin and pioglitazone by obesity and hypertriglyceridemia in a randomized crossover trial
por: Brandon, Rebecca, et al.
Publicado: (2023)

Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance.
por: Straczkowski, Marek, et al.
Publicado: (2003)

Variations in the Ghrelin Receptor Gene Associate with Obesity and Glucose Metabolism in Individuals with Impaired Glucose Tolerance
por: Mager, Ursula, et al.
Publicado: (2008)

Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes
por: Tönjes, Anke, et al.
Publicado: (2010)

Prevalence of impaired glucose tolerance and insulin resistance among obese children and adolescents
por: Ghergherechi, Robabeh, et al.
Publicado: (2010)

Impaired Glucose Tolerance and Visceral Adipose Tissue Thickness among Lean and Non-Lean People with and without Spinal Cord Injury
por: Kimball, Amy L., et al.
Publicado: (2023)

The Impact of Abnormal Glucose Tolerance and Obesity on Fetal Growth
por: Graves, Erin, et al.
Publicado: (2015)

Differential impact of impaired fasting glucose versus impaired glucose tolerance on cardiometabolic risk factors in multi-ethnic overweight/obese children
por: van Vliet, Mariska, et al.
Publicado: (2010)

Effects of Pioglitazone on Insulin Sensitivity and Serum Lipids in Obese Cats
por: Clark, M., et al.
Publicado: (2013)

In Vivo Insulin Sensitivity and Secretion in Obese Youth: What are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?
por: Bacha, Fida, et al.
Publicado: (2009)

Impaired Glucose Tolerance in Sleep Disorders
por: Keckeis, Marietta, et al.
Publicado: (2010)

Distinct β-Cell Defects in Impaired Fasting Glucose and Impaired Glucose Tolerance
por: Kanat, Mustafa, et al.
Publicado: (2012)

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
por: Liu, Yupu, et al.
Publicado: (2022)

The skin: A powerful hormone factory
por: Reichrath, Jörg
Publicado: (2012)

Effects of Insulin on Brain Glucose Metabolism in Impaired Glucose Tolerance
por: Hirvonen, Jussi, et al.
Publicado: (2011)

Allele Summation of Diabetes Risk Genes Predicts Impaired Glucose Tolerance in Female and Obese Individuals
por: Linder, Katarzyna, et al.
Publicado: (2012)

Risk factors of impaired glucose tolerance in obese children aged 12-15 years old
por: Kristiani, Francisca Yohanna Maria
Publicado: (2013)

Impact of obesity with impaired glucose tolerance on retinal degeneration in a rat model of metabolic syndrome
por: Godisela, Kishore Kumar, et al.
Publicado: (2017)

Impaired Glucose Tolerance, but Not Impaired Fasting Glucose, Underlies Left Ventricular Diastolic Dysfunction
por: Shimabukuro, Michio, et al.
Publicado: (2011)

Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
por: Liu, Jieying, et al.
Publicado: (2023)

Noninvasive Evaluation of Neural Impairment in Subjects With Impaired Glucose Tolerance
por: Putz, Zsuzsanna, et al.
Publicado: (2009)

Increased Sirt1 secreted from visceral white adipose tissue is associated with improved glucose tolerance in obese Nrf2-deficient mice
por: Braud, Laura, et al.
Publicado: (2020)

Pioglitazone Ameliorates Endothelial Dysfunction in Those with Impaired Glucose Regulation among the First-Degree Relatives of Type 2 Diabetes Mellitus Patients
por: Yu, Xuemei, et al.
Publicado: (2013)

Mechanism of impaired glucose tolerance in patients with neoplasia.
por: Jasani, B., et al.
Publicado: (1978)

Neuropathy of Impaired Glucose Tolerance and Its Measurement
por: Boulton, Andrew J.M., et al.
Publicado: (2010)

Impaired glucose tolerance with neurological manifestations in insulinoma
por: Villanueva‐Rodríguez, Luis Geraldine, et al.
Publicado: (2021)

Obesity-Associated Hepatosteatosis and Impairment of Glucose Homeostasis Are Attenuated by Haptoglobin Deficiency
por: Lisi, Simonetta, et al.
Publicado: (2011)

Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Pioglitazone: Indian perspective
por: Shukla, Rishi, et al.
Publicado: (2011)

Renal cyst growth is attenuated by a combination treatment of tolvaptan and pioglitazone, while pioglitazone treatment alone is not effective
por: Kanhai, Anish A., et al.
Publicado: (2020)

Prevalence, Diagnosis, and Treatment of Impaired Fasting Glucose and Impaired Glucose Tolerance in Nondiabetic U.S. Adults
por: Karve, Amrita, et al.
Publicado: (2010)

Effect of α-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance
por: McNeilly, Andrea M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7ag0du94qa7ugv2etsc9l26eri